Fig. 3From: Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective studyPatients undergoing monthly tegafur–uracil treatment were stratified according to different tumor locations: a < 6 and b ≥6 cm from the anal vergeBack to article page